SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 186 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,135,072 | +39.3% | 7,184 | +14.1% | 0.00% | 0.0% |
Q1 2024 | $814,951 | +4.0% | 6,295 | -22.6% | 0.00% | 0.0% |
Q4 2023 | $783,976 | -98.9% | 8,130 | -98.6% | 0.00% | -98.2% |
Q3 2023 | $71,802,606 | +5.7% | 592,333 | -0.2% | 0.06% | +7.8% |
Q2 2023 | $67,950,900 | -48.3% | 593,354 | -37.8% | 0.05% | -51.0% |
Q1 2023 | $131,379,832 | +48.5% | 953,204 | +39.6% | 0.10% | +44.4% |
Q4 2022 | $88,459,342 | -17.2% | 682,662 | -29.4% | 0.07% | -23.4% |
Q3 2022 | $106,859,000 | +20.4% | 966,697 | -18.4% | 0.09% | +28.8% |
Q2 2022 | $88,786,000 | +38.8% | 1,184,449 | +44.6% | 0.07% | +65.9% |
Q1 2022 | $63,986,000 | +15430.6% | 819,073 | +33760.0% | 0.04% | – |
Q4 2020 | $412,000 | +21.9% | 2,419 | +0.5% | 0.00% | – |
Q3 2020 | $338,000 | -11.7% | 2,407 | +0.8% | 0.00% | – |
Q2 2020 | $383,000 | -99.4% | 2,387 | -99.4% | 0.00% | -100.0% |
Q2 2019 | $61,923,000 | +37.3% | 407,524 | +7.7% | 0.06% | +34.8% |
Q1 2019 | $45,102,000 | -2.9% | 378,407 | -11.1% | 0.05% | -13.2% |
Q4 2018 | $46,444,000 | -29.3% | 425,580 | +4.6% | 0.05% | -17.2% |
Q3 2018 | $65,705,000 | +1307.6% | 406,820 | +545.7% | 0.06% | +1180.0% |
Q1 2018 | $4,668,000 | +47.0% | 63,009 | +10.4% | 0.01% | +66.7% |
Q4 2017 | $3,175,000 | -3.3% | 57,058 | -21.2% | 0.00% | 0.0% |
Q3 2017 | $3,284,000 | +76.2% | 72,394 | +30.9% | 0.00% | +50.0% |
Q2 2017 | $1,864,000 | +68.2% | 55,294 | +47.8% | 0.00% | +100.0% |
Q1 2017 | $1,108,000 | +7.3% | 37,417 | -0.6% | 0.00% | 0.0% |
Q4 2016 | $1,033,000 | -55.3% | 37,652 | +0.1% | 0.00% | -66.7% |
Q3 2016 | $2,309,000 | +254.7% | 37,598 | +10.1% | 0.00% | +200.0% |
Q2 2016 | $651,000 | -43.7% | 34,156 | +13.9% | 0.00% | 0.0% |
Q4 2015 | $1,157,000 | -28.4% | 29,987 | -40.4% | 0.00% | -50.0% |
Q3 2015 | $1,615,000 | +66.8% | 50,308 | +58.1% | 0.00% | +100.0% |
Q2 2015 | $968,000 | +107.3% | 31,823 | -9.6% | 0.00% | 0.0% |
Q1 2015 | $467,000 | -8.6% | 35,187 | -0.4% | 0.00% | 0.0% |
Q4 2014 | $511,000 | -27.4% | 35,339 | +5.9% | 0.00% | 0.0% |
Q3 2014 | $704,000 | -28.7% | 33,373 | +0.6% | 0.00% | 0.0% |
Q2 2014 | $988,000 | -25.3% | 33,182 | +18.5% | 0.00% | -50.0% |
Q3 2013 | $1,323,000 | +32.0% | 28,010 | +6.6% | 0.00% | +100.0% |
Q2 2013 | $1,002,000 | – | 26,280 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |